Intercept Pharmaceuticals Inc.

(ICPT) Trade

By |

Profile

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.

Contact Information

Website: www.interceptpharma.com
Email: info@interceptpharma.com
Main Phone: +1 646 747-1000
Address: 10 Hudson Yards
Address 2: 37th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10011

Issuer Information

Exchange: NGS
CEO: Mark Pruzanski
Employees: 507
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 96.00 $ 2.63 (2.82%)
Last Price 96.00 Change $ 2.63 Change % 2.82 Tick N/A
Bid 94.72 Bid Size 100.00 Ask 95.54 Ask Size 100.00
Open 93.70 High 96.59 Low 93.15 Prev Close 93.37
Last Trade Volume 388,826 52 Wk Hi 135.59 52 Wk Low 51.05
Market Cap 2.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 29,582,955.00 EPS (TTM) -13.99 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 60
Number of Buys 4 29
Number of Sells 0 31
Net Activity 251170 451095
Last 10 Buys Shares
Mark Pruzanski 1,000
Daniel M. Bradbury 1,000
Keith Gottesdiener 1,000
Luca Benatti 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Jonathan T. Silverstein 1,000
Srinivas Akkaraju 1,000
Last 10 Sell Shares
Richard Kim 1,000
Lisa Bright 1,000
Sandip S. Kapadia 1,000
Mark Pruzanski 1,000
Rachel McMinn 1,000
David Shapiro 1,000
David Shapiro 1,000
Lisa Bright 1,000
Lisa Bright 1,000
Lisa Bright 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 253 253 253 253
Low Target Price Estimate 57 57 57 57
Mean Target Price Estimate 116.23 116.23 116.23 116.23
Standard Deviation 60.13 60.13 60.13 60.13
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 06/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 7 7
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 1 1 1 1
Strong Sell 0 0 1 1
Mean Rec. 2.14 2.14 2.21 2.21